tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

LGVN Stock Latest News

Longeveron reports Q4 EPS (21c) vs (20c) last year
The FlyLongeveron reports Q4 EPS (21c) vs (20c) last year
14d ago
LGVN
Longeveron Inc. Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Press ReleasesLongeveron Inc. Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
14d ago
LGVN
Longeveron to Announce Fourth Quarter and Full Year Financial Results on March 10, 2023
Press ReleasesLongeveron to Announce Fourth Quarter and Full Year Financial Results on March 10, 2023
18d ago
LGVN
Longeveron Appoints Wa’el Hashad as Chief Executive Officer
Press ReleasesLongeveron Appoints Wa’el Hashad as Chief Executive Officer
24d ago
LGVN
Longeveron appoints Wa’el Hashad as Chief Executive Officer
The FlyLongeveron appoints Wa’el Hashad as Chief Executive Officer
24d ago
LGVN
Longeveron announces publication of final data from ELPIS I trial
The FlyLongeveron announces publication of final data from ELPIS I trial
2M ago
LGVN
Longeveron Announces Publication of Final Data from ELPIS I Trial of Lomecel-BTM for Hypoplastic Left Heart Syndrome in Peer-Reviewed Journal
Press ReleasesLongeveron Announces Publication of Final Data from ELPIS I Trial of Lomecel-BTM for Hypoplastic Left Heart Syndrome in Peer-Reviewed Journal
2M ago
LGVN
UPDATE — Longeveron Provides Corporate Update and Announces 2023 Strategic Priorities and Anticipated Milestones
Press ReleasesUPDATE — Longeveron Provides Corporate Update and Announces 2023 Strategic Priorities and Anticipated Milestones
3M ago
LGVN
Longeveron Provides Corporate Update and Announces 2023 Strategic Priorities and Anticipated Milestones
Press ReleasesLongeveron Provides Corporate Update and Announces 2023 Strategic Priorities and Anticipated Milestones
3M ago
LGVN
Longeveron provides corporate update, 2023 strategic priorities
The FlyLongeveron provides corporate update, 2023 strategic priorities
3M ago
LGVN
Longeveron to Participate in Upcoming 2022 Investor Conferences
Press ReleasesLongeveron to Participate in Upcoming 2022 Investor Conferences
4M ago
LGVN
Longeveron Inc. Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Press ReleasesLongeveron Inc. Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4M ago
LGVN
Longeveron announces completion of enrollment in Phase 2a trial of Lomecel-B
The FlyLongeveron announces completion of enrollment in Phase 2a trial of Lomecel-B
4M ago
LGVN
Longeveron Announces Completion of Enrollment in Phase 2a Trial of Lomecel-B™ for the Treatment of Alzheimer’s Disease
Press ReleasesLongeveron Announces Completion of Enrollment in Phase 2a Trial of Lomecel-B™ for the Treatment of Alzheimer’s Disease
4M ago
LGVN
Longeveron to Announce Third Quarter 2022 Financial Results on November 14, 2022
Press ReleasesLongeveron to Announce Third Quarter 2022 Financial Results on November 14, 2022
5M ago
LGVN
Longeveron to Present at the Annual Dawson James Small Cap Growth Conference
Press ReleasesLongeveron to Present at the Annual Dawson James Small Cap Growth Conference
6M ago
LGVN
Longeveron Names Jerome Bailey Vice President of Business Operations
Press ReleasesLongeveron Names Jerome Bailey Vice President of Business Operations
6M ago
LGVN
Longeveron to Present at H.C. Wainwright 24th Annual Global Investment Conference
Press ReleasesLongeveron to Present at H.C. Wainwright 24th Annual Global Investment Conference
7M ago
LGVN
U.S. Food and Drug Administration (FDA) Grants Fast Track Designation for Longeveron’s Lomecel-B™ Product for Treatment of Hypoplastic Left Heart Syndrome (HLHS) in Infants
Press ReleasesU.S. Food and Drug Administration (FDA) Grants Fast Track Designation for Longeveron’s Lomecel-B™ Product for Treatment of Hypoplastic Left Heart Syndrome (HLHS) in Infants
7M ago
LGVN
Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy Through Levels of Vascular Biomarker
Press ReleasesLongeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy Through Levels of Vascular Biomarker
7M ago
LGVN
Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2022 Financial Results
Press ReleasesLongeveron Inc. Provides Corporate Update and Reports Second Quarter 2022 Financial Results
7M ago
LGVN
Longeveron to Announce Second Quarter 2022 Financial Results on August 12, 2022
Press ReleasesLongeveron to Announce Second Quarter 2022 Financial Results on August 12, 2022
8M ago
LGVN